Get access

Role of rituximab for first-line or relapsed aggressive B-cell lymphoma

  • Protocol
  • Intervention

Authors


Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

The objective of this systematic review is to find all the available evidence comparing standard chemotherapy regimens with and without rituximab for patients with aggressive B-cell lymphoma.